At Syrhatech, we support our clients in the research and development of advanced technology. We operate in diverse sectors such as medical devices and regenerative medicine, demonstrating our adaptability to the specific needs of each industry.
Our latest R&D project focuses on an innovation in oral tissue regeneration aimed at enhancing gingival tissue repair through injectable hyaluronic acid. Known for its applications in medical aesthetics, dermatology, and wound healing, hyaluronic acid possesses key properties in hydration, healing, and biocompatibility with the human body.
Our client’s goal is to develop a proprietary advanced formulation capable of supporting natural gingival tissue regeneration and improving patients’ oral health.
As a CDMO (Contract Development and Manufacturing Organization), Syrhatech works closely with its clients to develop innovative solutions tailored to market needs.
Our expertise covers the development of hyaluronic acid-based medical devices, other water-soluble biopolymers, and the manufacturing of sterile biotech medical products.
Our versatility allows us to work on a wide range of projects, including dental care, orthopedic medical devices, aesthetic fillers, and Ophthalmic Viscosurgical Devices (OVD). We combine a rigorous scientific approach with optimized industrialization capabilities, ensuring our partners receive end-to-end support from design to manufacturing under an ISO 13485 certified process.
Why choose Syrhatech for your regenerative medicine projects?
- Biotech CDMO Company: We assist our clients at every stage, from formulation
to industrial scale-up. - Advanced Biopolymer Expertise: We develop solutions based on molecules like sodium hyaluronate for various medical applications.
- International Presence: Our clients come from different sectors and are located across Europe, Switzerland, and worldwide.
